<!DOCTYPE html><html><head><meta charset='utf-8'><meta name='viewport' content='width=device-width, initial-scale=1'><script async src='https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-8422244967817077' crossorigin=anonymous'></script><link rel='stylesheet' href='/class.css'><script src='/script.js'></script></head><body><div class='topnav'></div><div class='list'><Br/><a href='4140.html'>In order to furthe</a><Br/><a href='4141.html'>Reaction mechanism</a><Br/><a href='4142.html'>NHL and the NHL Sh</a><Br/><a href='4143.html'>Tissue factor path</a><Br/><a href='4144.html'>

Is there anythin</a><Br/><a href='4145.html'>Growing Green: Bus</a><Br/><a href='4146.html'>A single, large-sc</a><Br/><a href='4147.html'># Copyright 2019 T</a><Br/><a href='4148.html'>I just donâ€™t get i</a><Br/><a href='4149.html'>We have developed </a></div><div class='stats'><div class='logodiv'><a href='/'><img class='logoimg' src='/img/elephant.svg' /></a></div> <Br/><a href='4138.html'>Obituaries From Co</a><Br/><a href='4137.html'>A number of device</a><Br/><a href='4136.html'>

Dismissed and Me</a><Br/><a href='4135.html'>The authors confir</a><Br/><a href='4134.html'>Mission

A Mission</a><Br/><a href='4133.html'>Q:

In my Rails ap</a><Br/><a href='4132.html'>It's a mystery to </a><Br/><a href='4131.html'>If this is your fi</a><Br/><a href='4130.html'>Cochlear implants:</a><Br/><a href='4129.html'>The world of Star </a></div><div class='nav'><a href='4138.html'> << </a>&nbsp;&nbsp;&nbsp;&nbsp;<a href='4140.html'> >> </a></div><div class='article'>Novel inhibitors of human type II cAMP-specific phosphodiesterase isozyme with the cyclic 4',5'-imidazolone as a novel core structure.
New cAMP specific phosphodiesterase (PDE) inhibitors (type II PDE inhibitors) with the novel cyclic 4',5'-imidazolone as a novel core structure were designed and synthesized. Among the compounds, 2-adamantyl-5-(2'-pyrrolidinoylamino)methylimidazolone (11f) showed potent inhibitory activity in vitro, with Ki value of 3.2 x 10(-8) M. When used in combination with a phosphodiesterase-4 inhibitor Ro 20-1724, they significantly potentiated the elevation of cAMP levels in differentiated HL-60 cells, which suggests that the new cyclic 4',5'-imidazolone will be a promising scaffold for new type II PDE inhibitors.</div></body></html><!-- 2022-06-25 09:55:24 